Adjuvant Therapy of Colon Cancer: Where are we now ?
Columbia University Medical Center, New York
Anti-EGFR Antibodies in Metastatic Colorectal Cancer: Which Patients, When, and How? J. Randolph Hecht, MD David Geffen School of Medicine at UCLA.
Standard Management of Stage IV Colorectal Cancer: Start and Stop, Maintenance, Chemotherapy Holidays Jeffrey Meyerhardt, MD, MPH Dana-Farber Cancer Institute.
AGA/ASCO/ASTRO/SSO Gastrointestinal Cancers Symposium Orlando, FL January 26, 2008
Eric Van Cutsem*
Forging a new standard in metastatic CRC
2013 ASCO CRC Poster Discussion (Old Dog, New Tricks) Weijing Sun, MD, FACP University of Pittsburgh.
Oncogenes & tumour suppressors Bart Vanhaesebroeck Cell Signalling Group.
M. J. Pishvaian*, R. Slack*, A. Witkiewicz +, A. R. He*, J. J. Hwang*, A. Hankin*, K. Dorsch-Vogel*, D. Kuda*, T. McAndrew*, L. M. Weiner*, J. Marshall*,
2007 A.S.C.O. Annual Meeting Chicago (USA), June 1-5
Systemic Capecitabine and Oxaliplatin Administered with Hepatic Arterial Infusion (HAI) of Floxuridine (FUDR) Following Resection of Colorectal Metastases.
